Ann: Immuron Aims to Secure FDA Approval for IMM-124E, page-7

  1. 7,425 Posts.
    lightbulb Created with Sketch. 125
    very happy with that pathway......while they organising formal FDA approval we are still selling....so it won't affect our profits on TRAVELAN....other programs a bit slow but that is a biotech for you....this co needs lazy money is all....not long to go to see if our compounds are good enough to develop them further for NASH/ASH etc.....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.3¢
Change
0.000(0.00%)
Mkt cap ! $14.73M
Open High Low Value Volume
6.3¢ 6.3¢ 6.3¢ $816 12.95K

Buyers (Bids)

No. Vol. Price($)
1 30000 6.4¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 60163 2
View Market Depth
Last trade - 11.01am 08/07/2025 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.